TY - CHAP M1 - Book, Section TI - Noninfectious Disorders of the Ear A1 - Chan, Yvonne A1 - Goddard, John C. PY - 2019 T2 - K.J. Lee’s Essential Otolaryngology: Head and Neck Surgery, 12e AB - TraumaLacerations: simple with or without involved cartilage; stellate from blunt trauma; partial or total avulsionTreatment: Deep cleaning, debridement, surgical repair; may require stage or flap reconstruction; dressing, systemic antibiotics. Consider bolster to prevent hematoma.Complications: Perichondritis, cartilage necrosis.Hematoma—typically occur from blunt traumaTreatment: incision and drainage with through-and-through sutures and bolster dressing– Systemic antibiotics (consider fluoroquinolones)Complications: fibrosis, cauliflower/wrestlers ear, perichondritisFrostbite—exposure to subfreezing temperature and wind leading to disruption of endothelial layer with extravasation of erythrocytes, platelet aggregation, and sludgingSymptoms: pain, burning, discoloration; reduced pliability; loss of sensation.Treatment: slow warming; antibiotics; anticoagulants; debridement of necrotic tissue after demarcation. No pressure or pressure dressing to the ear.Bites—lobe of ear is most common siteTreatment: meticulous cleaning; systemic antibiotics; surgical repair and/or debridement– Human bites have greater propensity for infection.Keloids and hypertrophic scars—increased rates in African American and Histpanic population (up to 30%)Treatment: steroid injection, surgical excision, pressure dressing, rarely radiation therapyCarcinoma of the external ear6% of skin cancers involve the earLymphatic drainage—anterior auricular nodes: lateral pinna and anterior canal wall; postauricular nodes: superior and upper posterior pinna, posterior canal wall; superficial and deep cervical nodes: lobule and floor of external ear canalMetastasis assocaited with depth of invasionStaging:Skin and pinna– TX—Primary tumor cannot be assessed.– T0—No evidence of primary tumor.– Tis—Carcinoma in situ.– T1—Tumor 2 cm or less.– T2—Tumor larger than 2 cm but smaller than 5 cm.– T3—Tumor larger than 5 cm.– T4—Tumor invades deep extradermal structures (bone, muscle, cartilage).University of Pittsburgh staging system for SCC involving the temporal bone– T1—Tumor limited to external auditory canal without bone or soft tissue extension– T2—Tumor with limited external auditory canal bony erosion or less than 0.5 cm soft tissue involvement– T3—Tumor eroding full thickness bony external auditory canal with less than 0.5 cm soft tissue involvement, or tumor invovling the middle ear and/or mastoid– T4—Tumor eroding the medial wall of middle ear or beyond, or less than 0.5 cm soft tissue involvement, or patient with facial nerve paresis or paralysisRegional lymph nodes:– NX—Regional lymph nodes cannot be assessed.– N0—No regional lymph node metastasis.– N1—Regional lymph node metastasis.Basal cell carcinoma—most common malignancy of the ear (45%)Symptoms: erythematous lesion with raised margins; silvery scales common, occurs on the pinna and in the external canalTreatment: biopsy, topical agents, wide local excision; may require cartilage excision, skin graft, or local flapsSquamous cell carcinomaSymptoms: pain, bloody discharge, polyp with granular appearance, facial nerve paralysis, hearing lossTreatment: biopsy, wide surgical excision, may require parotidectomy, sleeve resection of ear canal or temporal bone resection; postoperative radiation for advanced casesMalignant melanoma—7% of head and neck sites involve the earOther tumors of the ear: adenoid cystic carcinoma, adenocarcinoma, adenoma, pleomorphic adenoma SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/18 UR - accesssurgery.mhmedical.com/content.aspx?aid=1172370123 ER -